-
1
Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves’ orbitopathy
Published 2024-09-01Subjects: “…graves’ orbitopathy…”
Get full text
Article -
2
Incidence and risk factors for Graves’ orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves’ disease: investi...
Published 2023-11-01Subjects: “…graves’ orbitopathy…”
Get full text
Article -
3
Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
Published 2024-04-01Subjects: “…graves’ orbitopathy…”
Get full text
Article